travellinglight/iStock via Getty Images
- Eisai (OTCPK:ESALF), Biogen’s (NASDAQ:BIIB) partner for Alzheimer’s therapy Leqembi is planning to launch its at-home version of the drug in fiscal 2025, Japanese business publication Nikkei Asia reported Thursday.
- “The new formulation will be a game changer in Alzheimer’s treatment,” Eisai (